Second annual report from the ISHLT Mechanically Assisted Circulatory Support Registry

James K. Kirklin; Rongbing Xie; Jennifer Cowger; Theo M.M.H. de By; Takeshi Nakatani; Stephan Schueler; Rhiannon Taylor; Jenny Lannon; Paul Mohacsi; Jan Gummert; Daniel Goldstein; Kadir Caliskan; Margaret M. Hannan

doi:10.1016/j.healun.2018.01.1294

Second annual report from the ISHLT Mechanically Assisted Circulatory Support Registry

James K. Kirklin^*, Rongbing Xie, Jennifer Cowger, Theo M.M.H. de By, Takeshi Nakatani, Stephan Schueler, Rhiannon Taylor, Jenny Lannon, Paul Mohacsi, Jan Gummert, Daniel Goldstein, Kadir Caliskan, Margaret M. Hannan

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

119 Citations (Scopus)

Abstract

The second annual IMACS registry report includes over 14, 000 patients from 35 countries. Survival, adverse events, and an updated risk model is presented. Continuous flow pumps continue to dominate the world's experience. One and Two-year survival remains at 80% and 70%. Congenital heart disease and biventricular support are the most dominant risk factors. The database is poised for major novel analyses.

Original language	English
Pages (from-to)	685-691
Number of pages	7
Journal	Journal of Heart and Lung Transplantation
Volume	37
Issue number	6
DOIs	https://doi.org/10.1016/j.healun.2018.01.1294
Publication status	Published - Jun 2018
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2018 International Society for the Heart and Lung Transplantation

Access to Document

10.1016/j.healun.2018.01.1294

Cite this

Kirklin, J. K., Xie, R., Cowger, J., de By, T. M. M. H., Nakatani, T., Schueler, S., Taylor, R., Lannon, J., Mohacsi, P., Gummert, J., Goldstein, D., Caliskan, K., & Hannan, M. M. (2018). Second annual report from the ISHLT Mechanically Assisted Circulatory Support Registry. Journal of Heart and Lung Transplantation, 37(6), 685-691. https://doi.org/10.1016/j.healun.2018.01.1294

@article{9c32002e2d944b178282e31353dd33bc,

title = "Second annual report from the ISHLT Mechanically Assisted Circulatory Support Registry",

abstract = "The second annual IMACS registry report includes over 14, 000 patients from 35 countries. Survival, adverse events, and an updated risk model is presented. Continuous flow pumps continue to dominate the world's experience. One and Two-year survival remains at 80% and 70%. Congenital heart disease and biventricular support are the most dominant risk factors. The database is poised for major novel analyses.",

author = "Kirklin, {James K.} and Rongbing Xie and Jennifer Cowger and {de By}, {Theo M.M.H.} and Takeshi Nakatani and Stephan Schueler and Rhiannon Taylor and Jenny Lannon and Paul Mohacsi and Jan Gummert and Daniel Goldstein and Kadir Caliskan and Hannan, {Margaret M.}",

note = "Publisher Copyright: {\textcopyright} 2018 International Society for the Heart and Lung Transplantation",

year = "2018",

month = jun,

doi = "10.1016/j.healun.2018.01.1294",

language = "English",

volume = "37",

pages = "685--691",

journal = "Journal of Heart and Lung Transplantation",

issn = "1053-2498",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Second annual report from the ISHLT Mechanically Assisted Circulatory Support Registry

AU - Kirklin, James K.

AU - Xie, Rongbing

AU - Cowger, Jennifer

AU - de By, Theo M.M.H.

AU - Nakatani, Takeshi

AU - Schueler, Stephan

AU - Taylor, Rhiannon

AU - Lannon, Jenny

AU - Mohacsi, Paul

AU - Gummert, Jan

AU - Goldstein, Daniel

AU - Caliskan, Kadir

AU - Hannan, Margaret M.

PY - 2018/6

Y1 - 2018/6

N2 - The second annual IMACS registry report includes over 14, 000 patients from 35 countries. Survival, adverse events, and an updated risk model is presented. Continuous flow pumps continue to dominate the world's experience. One and Two-year survival remains at 80% and 70%. Congenital heart disease and biventricular support are the most dominant risk factors. The database is poised for major novel analyses.

AB - The second annual IMACS registry report includes over 14, 000 patients from 35 countries. Survival, adverse events, and an updated risk model is presented. Continuous flow pumps continue to dominate the world's experience. One and Two-year survival remains at 80% and 70%. Congenital heart disease and biventricular support are the most dominant risk factors. The database is poised for major novel analyses.

UR - http://www.scopus.com/inward/record.url?scp=85043505263&partnerID=8YFLogxK

U2 - 10.1016/j.healun.2018.01.1294

DO - 10.1016/j.healun.2018.01.1294

M3 - Article

C2 - 29550146

AN - SCOPUS:85043505263

SN - 1053-2498

VL - 37

SP - 685

EP - 691

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

IS - 6

ER -

Second annual report from the ISHLT Mechanically Assisted Circulatory Support Registry

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this